These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35155161)

  • 21. Gallbladder cancer integrated bioinformatics analysis of protein profile data.
    Zali MR; Zamanian Azodi M; Razzaghi Z; Heydari MH
    Gastroenterol Hepatol Bed Bench; 2019; 12(Suppl1):S66-S73. PubMed ID: 32099604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma.
    Guo Y; Zhang Y; Zhang SJ; Ma YN; He Y
    BMC Med Genomics; 2019 May; 12(1):73. PubMed ID: 31138194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA binding motif protein 3 (RBM3) drives radioresistance in nasopharyngeal carcinoma by reducing apoptosis via the PI3K/AKT/Bcl-2 signaling pathway.
    Ma R; Zhao LN; Yang H; Wang YF; Hu J; Zang J; Mao JG; Xiao JJ; Shi M
    Am J Transl Res; 2018; 10(12):4130-4140. PubMed ID: 30662656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM21-SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis.
    Zhang P; Li X; He Q; Zhang L; Song K; Yang X; He Q; Wang Y; Hong X; Ma J; Liu N
    J Biomed Sci; 2020 Jan; 27(1):30. PubMed ID: 32005234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
    Feng X; Lv W; Wang S; He Q
    Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation.
    Zhang G; Wang W; Yao C; Ren J; Zhang S; Han M
    Biomed Pharmacother; 2017 Jul; 91():147-154. PubMed ID: 28453992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
    Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
    Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.
    Zhou L; Chen HM; Qu S; Li L; Zhao W; Liang ZG; Yu BB; Chen KH; Lu QT; Lin GX; Zhu XD
    Oncotarget; 2018 Jan; 9(3):3230-3241. PubMed ID: 29423042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis.
    Chen L; Zhou H; Guan Z
    Biochem Biophys Res Commun; 2019 May; 512(4):786-792. PubMed ID: 30928094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
    Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
    Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating of Gene Expression Alteration after Garlic Consumption, Analyzing through Bioinformatics Approach.
    Esmaeili S; Rostami-Nejad M; Rezaei-Tavirani M; Okhovatian F; Mehdi Zadeh-Esmaeel M; Razzagh Z; Ahmadzadeh A; Vafaee R
    Iran J Pharm Res; 2021; 20(1):72-81. PubMed ID: 34400942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.
    Gao R; Feng Q; Tan G
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189740
    [No Abstract]   [Full Text] [Related]  

  • 35. CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells.
    Shen L; Li C; Chen F; Shen L; Li Z; Li N
    Cell Death Discov; 2021 Dec; 7(1):392. PubMed ID: 34907164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma.
    Qu Y; Zhang H; Zhao S; Hong J; Tang C
    Oncol Rep; 2010 Apr; 23(4):1005-11. PubMed ID: 20204285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.
    Huang W; Shi G; Yong Z; Li J; Qiu J; Cao Y; Zhao Y; Yuan L
    Cell Death Dis; 2020 Jul; 11(7):504. PubMed ID: 32632129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis.
    Saki K; Mansouri V; Abdi S; Fathi M; Razzaghi Z; Haghazali M
    Gastroenterol Hepatol Bed Bench; 2021; 14(Suppl1):S94-S101. PubMed ID: 35154608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells.
    Li Z; Li N; Shen L; Fu J
    Front Oncol; 2018; 8():548. PubMed ID: 30524968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of inflammatory bowel disease biomarkers panel using protein-protein interaction (PPI) network analysis.
    Asadzadeh-Aghdaee H; Shahrokh S; Norouzinia M; Hosseini M; Keramatinia A; Jamalan M; Naghibzadeh B; Sadeghi A; Jahani Sherafat S; Zali MR
    Gastroenterol Hepatol Bed Bench; 2016 Dec; 9(Suppl1):S8-S13. PubMed ID: 28224022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.